HCM
CASI

Howland Capital Management’s CASI Pharmaceuticals CASI Stock Holding History

Howland Capital Management’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-15,072
Closed -$82.9K – 278
2024
Q2 		$82.9K Sell
15,072
-25,357
-63% -$78.8K ﹤0.01% 272
2024
Q1 		$146K Buy
+40,429
New +$218K 0.01% 262
2017
Q4 		– Sell
-2,414
Closed -$43K – 221
2017
Q3 		$43K Buy
+2,414
New +$28.2K ﹤0.01% 220

Other funds holding CASI

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return